The Staphylococcus aureus leucine aminopeptidase is localized to the bacterial cytosol and demonstrates a broad substrate range that extends beyond leucine Abstract: Staphylococcus aureus is a potent pathogen of humans exhibiting a broad disease range, in part due to an extensive repertoire of secreted virulence factors, including proteases. Recently, we identified the first example of an intracellular protease (leucine aminopeptidase, LAP) that is required for virulence in S. aureus . Disruption of pepZ , the gene encoding LAP, had no affect on the growth rate of bacteria; however, in systemic and localized infection models the pepZ mutant had significantly attenuated virulence. Recently, a contradictory report was published suggesting that LAP is an extracellular enzyme and it is required for growth in S. aureus . Here, we investigate these results and confirm our previous findings that LAP is localized to the bacterial cytosol and is not required for growth. In addition, we conduct a biochemical investigation of purified recombinant LAP, identifying optimal conditions for enzymatic activity and substrate preference for hydrolysis. Our results show that LAP has a broad substrate range, including activity against the dipeptide cysteine-glycine, and that leucine is not the primary target of LAP.
Introduction
Aminopeptidases are a class of proteolytic enzymes that selectively hydrolyze single amino acids or dipeptides from the N-termini of proteins. Best studied for their role in peptide metabolism and protein turnover, they have recently received increased attention as they are frequently linked to virulence in a number of protozoan and bacterial species. Of particular interest, in Plasmodium falciparum two aminopeptidases are involved in the final stages of hemoglobin degradation (Dalal and Klemba , 2007 ) . Loss of aminopeptidase activity due to the addition of inhibitors, such as bestatin, interrupts the parasitic lifecycle, making this enzyme a promising target for anti-malaria drugs (Skinner -Adams et al., 2009 ). There is concern that aminopeptidases are ubiquitous in all domains of life, therefore in order to develop them further as viable drug targets, a thorough understanding of their mechanisms of action, in particular the differences that exist in specificity of host and pathogen aminopeptidases, is crucial.
Staphylococcus aureus is a versatile Gram-positive bacterial pathogen, and a major public health concern due to the rise of strains that are resistant to most frontline antibiotics. As a result, there is an urgent need for new approaches to combat and treat S. aureus infections. Recently, we demonstrated an aminopeptidase that is required for virulence in Gram-positive bacteria for the first time . LAP is an M17 family metalloaminopeptidase required for virulence in S. aureus . Strains of S. aureus containing a mutation in pepZ (the gene encoding LAP) demonstrated no growth defects, however they had severely attenuated virulence in a number of mouse infection models. Our studies showed that the expression of pepZ was induced in the host ' s intracellular environment, and that LAP was localized to the bacterial cytosol.
Despite this demonstration that LAP contributes to S. aureus infection, the mechanism by which it contributes to pathogenesis is unknown. S. aureus secretes a number of extracellular proteases that are involved in virulence (Shaw et al. , 2004 ; Kantyka et al. , 2011 ) . These proteases are known to contribute to disease causation by targeting host and/or bacterial proteins in the extracellular milieu; however as an intracellular protease this is not the case for LAP. It is likely that LAP targets as yet unknown intracellular bacterial proteins, and in this way influences the infectious process. Identification of these intracellular targets of LAP will provide a valuable insight into the mechanism of action of this protease, the pathogenic mechanisms of S. aureus , and potentially aid in the design of inhibitor molecules as antibacterial therapeutics.
The M17 family of leucine-aminopeptidases was initially named because of their ability to hydrolyze leucine (Leu; Matsui et al. , 2006 ) . However, most members of this family exhibit a substrate range that is fairly broad and frequently includes the amino acids Met, Ala, Arg, Ile and others, in addition to Leu (Morty and Morehead , 2002 ; Lin et al. , 2004 ; Dong et al. , 2005 ; Stack et al. , 2007 ) . In addition to substrate variation, the conditions required for enzymatic activity can also differ. While in general LAPs are functional at pH 8 -9, their activity in the presence of divalent metal ions tends to vary from strain to strain. Typically, enzymatic activity is optimal with Mn 2 + as a cofactor; however activity is also frequently observed with Ni 2 + and Co 2 + , and to a lesser extent with other metals (Morty and Morehead , 2002 ; Dong et al. , 2005 ; Jia et al. , 2009 ) . To better understand the role of S. aureus LAP in infection, and to aid in identifying intracellular targets, we undertook an in-depth investigation into the biochemical characteristics and substrate preference of the protease.
While our previous study was in review, another investigation reported contradictory findings with regard to S. aureus LAP (Singh et al. , 2012 ) . Singh et al. reported that LAP was found in both intracellular protein fractions and extracellular culture supernatants, suggesting that it is secreted. They also reported that inhibition of LAP with bestatin in the culture medium disrupted the ability of bacteria to form biofilms, and slowed growth rates. In our study, the disruption of pepZ (and loss of LAP) had no affect on bacterial viability in a number of different media tested.
Herein, we further investigate the localization of LAP and its role in growth and biofilm formation. We confirm our previous findings that LAP is an intracellular enzyme, and suggest an explanation for the contradictory results that were recently published. Additionally, to understand the biological function of LAP, we purify a recombinant form of the protein and conduct a biochemical characterization of the optimal reaction conditions and metal cofactors required for activity of the enzyme. We perform an investigation into the substrate preferences of LAP, and reveal that it efficiently hydrolyzes a number of amino acids in addition to Leu and also cleaves the dipeptide cysteine-glycine, raising interesting possibilities regarding its role in vivo during the Staphylococcal infectious process.
Results

LAP is an intracellular enzyme
In a previous study we reported that LAP was located intracellularly . This result was in contrast to recent data published by Singh et al., where LAP was reported to be found in culture supernatants (Singh et al. , 2012 ) . To investigate the discrepancy in results between the two studies, we repeated our Western blot analysis. Intracellular and extracellular protein fractions from wild-type S. aureus USA300 expressing histidine (His)-tagged LAP from a plasmid, and from USA300 containing an empty vector control, were used. As previously reported by us, LAP-His was only detected in the intracellular fraction from the strain expressing the LAP-His plasmid (Figure 1 A) . No LAP-His was detected in the culture supernatant fraction from this strain, or from the intracellular/extracellular fractions from the strain containing the empty vector control. Interestingly, when the Western blot was overexposed to X-ray film, a weak band appeared in both lanes corresponding to extracellular fractions ( Figure 1B ). This band was of equal intensity in both samples, and ran at an apparent molecular weight similar to, but slightly larger than, LAP-His. The empty vector control contained no LAP-His, therefore this band does not correspond to secreted LAP. It is likely that this band represents protein A, which is secreted into the culture supernatant. Protein A non-specifically binds antibodies, is approximately the same size as LAP ( ~ 54 kDa), and is frequently observed on Western blots using S. aureus protein fractions. We suggest that the band observed by Singh et al. in the extracellular fractions of their Western blots also corresponds to protein A, and that LAP is only found in the bacterial cytosol (Singh et al. , 2012 ) . This result confirms our previous findings that LAP is an intracellular protein and explains the discrepancy in results.
Inhibition of LAP with bestatin does not adversely affect the growth of S. aureus
Previously it was reported that inhibition of LAP using the protease inhibitor bestatin led to a decrease in the growth rate of S. aureus in tryptic soy broth (TSB) (Singh et al. , 2012 ) . This result suggests that LAP is required for maximal growth in rich media, which our previous data suggested was not the case . To further investigate the affect of LAP on the growth rate of bacteria, we repeated our growth analysis using wildtype USA300, a USA300 pepZ mutant, and the complemented pepZ strain. Growth was performed with and without bestatin at 50 μ g ml -1
, a concentration previously shown to impair the growth of S. aureus (Singh et al. , 2012 ) . As previously observed by us, there was no difference in growth between the wild type and the pepZ mutant (Figure 2 A) . Furthermore, the addition of bestatin did not impact the growth of any strain. Together these data support the hypothesis that LAP is not required for growth in TSB, and that the addition of bestatin to culture medium does not affect bacterial growth. LAP is not required for biofilm formation Singh et al. reported that inhibition of LAP with bestatin led to a decrease in biofilm formation, suggesting that LAP has a role in this process (Singh et al. , 2012 ) . Biofilms are complex multicellular structures and their formation is known to involve a number of bacterial proteases. Therefore, it is possible that the addition of a protease inhibitor may have pleiotropic affects, and that any differences observed may not be due to the targeted inhibition of one protease. To more specifically determine the role of LAP in biofilm formation, we performed biofilm assays with wild-type S. aureus , its pepZ mutant and pepZ complemented strains. As different strains of S. aureus have different biofilm-forming capabilities, we performed these assays in both USA300 and in SH1000, a strain known to be proficient in biofilm formation (Kolar et al. , 2011 ) . Results show that in both backgrounds tested there was no difference in biofilm formation between the wild type, pepZ mutant, and pepZ complemented strains ( Figure 2B and C). This indicates that LAP is not required for biofilm formation, and suggests that the defect in biofilm formation observed by Singh et al. upon the addition of bestatin is due to the pleiotropic affects of this inhibitor on bacterial cells.
LAP is not the primary leucine aminopeptidase of S. aureus
A previous study in our lab demonstrated that S. aureus LAP, an M17 family member, is required for virulence in numerous mouse models of infection . To begin to understand how LAP contributes to pathogenesis, we investigated the enzymatic properties of this enzyme, beginning with its Leu aminopeptidase activity. Interestingly, there is not one but two Leu aminopeptidases encoded in the S. aureus genome: LAP and another enzyme referred to as PepS (SACOL1937). PepS is an uncharacterized M29 family member leucine aminopeptidase in S. aureus , whose crystal structure has been determined (Odintsov et al. , 2005 ) . The presence of two leucine aminopeptidases in the S. aureus genome suggests that either: (i) there is functional redundancy between the two enzymes; or (ii) one or both of these proteases have substrates in addition to Leu. M17 family members are frequently active against a broad range of substrates in addition to Leu, while M29 family members tend to have a narrower substrate range. To test the relative contribution of each enzyme to cellular leucine aminopeptidase activity, we performed a series of Leu-7-amido-4-methylcoumarin (AMC) hydrolysis assays using whole cell lysates from an S. aureus wild-type strain, or its pepZ and pepS mutant derivatives.
Equal quantities of whole cell lysates were incubated with Leu-AMC, and subsequent AMC release as a result of cleavage was determined (excitation wavelength 360 nm, emission wavelength 460 nm). Following 60 min of incubation, lysates from wild-type S. aureus demonstrated high leucine aminopeptidase activity ( Figure 3 ). In contrast, lysates from pepS mutant cells demonstrated a dramatic reduction in leucine aminopeptidase activity (a 33-fold decrease compared to the wild type). Interestingly, lysates from pepZ mutant cells showed leucine aminopeptidase activity comparable to that of the wild-type strain.
These results suggest that the majority of leucine aminopeptidase activity observed in S. aureus cells comes from PepS, and not LAP. Although the pepS lysates demonstrate greatly reduced leucine aminopeptidase activity, some residual proteolysis was still observed in these samples. While it is possible that this activity is due to Wild-type USA300, USA300 pepZ mutant, and USA300 pepZ complement strains were grown in tryptic soy broth (TSB) with and without the aminopeptidase inhibitor bestatin. No difference in growth was observed between any of the strains in any condition tested. (B) The wild-type, pepZ mutant and pepZ complemented strains of USA300 and SH1000 were used in biofilm formation assays. The ability of each wild-type strain to form biofilms varied, however the biofilm formation capabilities of each strain were not affected in the pepZ mutant or pepZ complemented strains. Assays were performed in duplicate and a representative data set is shown. Figure 3 The leucine aminopeptidase activity of S. aureus bacterial lysates.
Whole-cell lysates from wild-type USA300, USA300 pepS and USA300 pepZ mutant strains were used in leucine-AMC hydrolysis assays. Experiments were performed in triplicate and the data shown are the average of three independent experiments. Error bars represent the standard deviation. Significance was determined by t -test.
LAP, these results strongly suggest that cleavage of Leu is not the primary function of LAP within the cell.
Optimization of LAP enzymatic reaction conditions
Given that the data above suggest that LAP is likely to have a substrate range beyond Leu, we next set out to explore the cleavage preference of this enzyme. To do this, we first identified the optimal reaction conditions required for enzymatic activity. Here, we used Leu-AMC, a substrate that is known to be cleaved by M17 family members and has previously been shown to be a substrate for LAP (Singh et al. , 2012 ) . Incubating 0.5 m m Leu-AMC with increasing concentrations of purified recombinant LAP-His resulted in a concentration-dependent increase in fluorescence over time, as expected for an enzymatic reaction (Figure 4 A). This result confirms that Leu-AMC is hydrolyzed by LAP and that the reaction occurs in a dosedependent manner. M17 family aminopeptidases require divalent metal ions for proteolysis (Matsui et al. , 2006 ) . For most family members, activity is highest with Mn 2 + , while Ni 2 + and Co 2 + also promote activity, albeit to a lesser degree (Dong et al. , 2005 ; Chu et al. , 2008 ; Singh et al. , 2012 ) . To further optimize reaction conditions for LAP, we determined the optimum concentration of MnCl 2 required for enzymatic activity. The Leu-AMC hydrolysis assay was performed with a range of concentrations of We next performed the Leu-AMC hydrolysis assay in a variety of different buffers to determine the optimal conditions for activity. As M17 family members frequently demonstrate higher activity at pH 8 -10, we compared the activity of LAP in three buffers at pH 9 to activity in sodium phosphate buffer at pH 7.4. Results show higher activity for LAP in all three buffers at pH 9, with the highest levels of activity observed in N-cyclohexyl-3-aminopropanesulfonic acid (CAPS) and N-Tris(hydroxymethyl)methyl-3-aminopropanesulfonic acid (TAPS) ( Figure 4C ). Due to the greater buffering capacity of TAPS at pH 9, all subsequent enzymatic analyses were performed in this buffer. Leucine-AMC hydrolysis assays were performed in three different buffers at pH 9. The activity of LAP in these buffers was compared to activity in phosphate buffer at pH 7.4 and is expressed as fold increase.
Metal and pH activity profiling of LAP
Having determined the optimal reaction conditions for the Leu-AMC hydrolysis assay, we next set out to comprehensively determine the divalent metal ion and pH preference of LAP. Previous studies on this enzyme have reported high activity in the presence of Mn 2 + , Ni 2 + and Co 2 + at pH 8.5 (Singh et al. , 2012 ) . However, this study only examined pH preference in the presence of MnCl 2 and divalent metal ion preference at pH 8.5, using a concentration of divalent metal ions (1 m m ) found to be suboptimum in our assays ( Figure 4B ).
To gain a comprehensive metal/pH activity profile for LAP, we performed the Leu-AMC hydrolysis assay in the presence of seven different divalent ions (Mn and Cd 2 + was similar, with maximal activity around pH 9, while activity in the presence of Ni 2 + was maximal at pH 7. These results show that LAP is functional in the presence of multiple divalent ions and under multiple pH conditions. Interestingly, the presence of different divalent ions can influence the pH at which the enzyme is most active.
LAP exhibits a broad substrate range
The result above (Figure 3) suggests that Leu is not the primary substrate of LAP. This is consistent with other M17 family aminopeptidases (Chu et al. , 2008 ) . To further investigate the substrate range of LAP, we performed hydrolysis assays using a unique library of 60 fluorogenic substrates derived from both naturally-occurring and unnatural amino acids (Poreba et al. , 2012 ). This recentlydescribed technique generates an enzyme-specific ' substrate fingerprint ' .
Upon analysis, we determined that LAP has a rather broad, yet varying, substrate range among the naturallyoccurring amino acids (Figure 6 A) . Low levels of activity were observed against threonine and tryptophan, while higher levels were observed against Leu, Lys and Met. Interestingly, the highest levels of activity demonstrated by LAP in this assay were not against Leu, but against alanine and arginine (approximately two-fold higher than for Leu). This demonstrates that the substrate range of LAP is quite complex, and that Leu is not the preferred substrate under the conditions tested.
Hydrolysis by LAP was also observed for a large number of unnatural amino acids. The highest levels of activity were detected against L-hArg and L-Phg ( Figure  6B ). The activity against these substrates was higher than that observed against the naturally-occurring amino acids alanine and arginine (approximately 1.5-fold higher) and Leu (approximately 3.5-fold higher). High levels of activity were also observed against L-hPhe, 4-NH 2 -L-Phe, L-hLeu, L-hCha and L-Nle. No activity was observed against substrates without α -amines, as previously shown for aminopeptidases (Kasperkiewicz et al. , 2012 ) .
The results above suggest the substrate preference of LAP in these assays is hArg/Phg > Ala/Arg > Leu/Lys/Met. To confirm this result, we determined the k ca t / K m ratio for hArg, Phg, Arg and Leu (Table 1 ) . Results from the kinetic analysis confirm the data from the initial screen. Of the two naturally-occurring amino acids selected, LAP shows a higher preference for arginine than Leu (176. compared to 87.25 M -1 s -1 ). Activity against the unnatural amino acids hArg and Phg was higher than activity against either Leu or alanine (as previously shown, see Figure 6 ) with Phg being the preferred substrate of the four tested.
LAP possesses cysteinylglycinase activity
Many M17 family members have been shown to demonstrate cysteinylglycinase activity in addition to leucine aminopeptidase activity. Indeed, for some M17 members, cysteine-glycine is the preferred substrate for the enzyme (Chu et al. , 2008 ) . Previously, homology studies have suggested that LAP is a potential cysteinylglycinase in S. aureus (Soutourina et al. , 2009 ). This, in addition to the results above (suggesting leucine aminopeptidase activity is not the primary function of LAP, see Figure 3 ), led us to hypothesize that LAP may be a cysteinylglycinase. To test this hypothesis, we next preformed a cysteine-glycine hydrolysis assay. Our results with the Leu-AMC hydrolysis assay show that LAP has different activity at different pH/ metal conditions; therefore we performed the cysteineglycine hydrolysis assay using the same range of metals and pH conditions employed earlier. In contrast to the results from Leu-AMC hydrolysis, where multiple metal/ pH combinations resulted in LAP activity, only one condition tested resulted in cysteine-glycine activity (Figure 7 ). In the presence of MnCl 2 at pH 7, LAP demonstrated strong activity towards the cysteine-glycine substrate. LAP was not functional against cysteine-glycine under any of the other conditions tested.
We next determined the kinetic parameters for cysteine-glycine activity. The k cat /K m ratio against cysteineglycine is 534.02 M -1 s -which is higher that the k cat /K m ratio for any other substrate tested (Table 1 ) . Although the kinetic parameters for cysteine-glycine activity were determined under different reaction conditions than the four other substrates tested (i.e., pH 7 vs. pH 9), these results suggest that the highest levels of LAP activity are against cysteine-glycine. Together these results show that LAP is functional as a cysteinylglycinase, that the conditions required for LAP cysteinylglycinase activity are more stringent than for leucine aminopeptidase activity, and that cysteine-glycine may be the preferred substrate for LAP.
Discussion
S. aureus is a highly versatile pathogen of humans and is a major public health concern due to the continued emergence of drug-resistant strains. An in-depth understanding of the organism and its mechanisms of virulence is needed to design effective therapies and treatments to combat the rise in antibiotic resistance. Recently, we identified an intracellular leucine aminopeptidase that is required for virulence in S. aureus . In this study, we set out to gain an insight into the in vivo targets of LAP by determining the substrate preference of the purified recombinant protein. In addition to this, to address the contradictory findings of Singh et al. with regard to the localization and function of LAP, we examined the discrepancy in results between the two studies (Singh et al. , 2012 ) . Our analyses confirmed that LAP is localized to the bacterial cytosol and demonstrated that LAP is not required for biofilm formation in S. aureus .
While our previous study demonstrated that LAP is required for virulence in S. aureus , the specific mechanism by which it contributes to pathogenesis is unknown. Expression of the pepZ gene is induced inside macrophages, therefore we hypothesize that LAP is required ). Cysteine-glycine hydrolysis was measured by the release of free cysteine using the ninhydrin reagent measured at OD 560 . Data shown are the average from three replicates with error bars representing standard deviation.
during infection for the N-terminal hydrolysis of some as yet unknown intracellular target . In the absence of LAP, the loss of aminopeptidase activity towards such a substrate leads to the altered virulence phenotypes observed. To investigate this hypothesis, we began by purifying a recombinant form of LAP and determining its optimal reaction conditions and substrate specificity profile in vitro . This substrate specificity profile will help in future investigations into the cellular target of LAP.
Previous studies have only examined a limited number of pH/metal combinations and determined that LAPs leucine aminopeptidase activity is optimal at pH 8.5 in the presence of Mn , however unlike this study they also demonstrated activity with Co 2 + . The differences in buffer composition and metal ion concentration used may account for these discrepancies. Interestingly, we also demonstrated the activity of LAP in the presence of Cd 2 + . To our knowledge, examples of M17 family members activated by Cd 2 + are rare, with the only other example being the PepB protein from Escherichia coli (Suzuki et al. , 2001 ). It will be interesting to determine whether Cd 2 + activation is a prokaryotic-specific trend amongst M17 family members.
One interesting observation from our pH/metal analysis was that the activity of LAP in the presence of a particular metal varies according to the pH. For example, in the presence of Mn 2 + LAP activity is maximal at pH 9, while in the presence of Ni 2 + optimal activity was observed at pH 7. These results raise the intriguing prospect that the activity of LAP may be modified by interacting with different metal ions. This idea is supported by previous studies where the introduction of Mn 2 + into site 1 of bovine lens LAP causes the enzyme to be active against cysteine-glycine (see discussion below) (Cappiello et al. , 2004 (Cappiello et al. , , 2006 .
Having determined the optimal conditions for LAP activity, we next investigated the substrate specificity profile of LAP using a library of 60 fluorogenic substrates. This library consists of 19 naturally-occurring amino acids (cysteine is absent due to its susceptibility to oxidation) and 41 unnatural amino acids coupled to the fluorophore 7-amino-4-carbamoylmethylcoumarin (ACC). Among the 19 natural amino acids, Leu was not the preferred substrate of LAP. Alanine and arginine were the preferred substrates, with Leu, lysine and methionine demonstrating slightly lower affinity. Low levels of activity were also observed against threonine and tryptophan. Interestingly, this profile among the naturally-occurring amino acids very closely resembles that of the P. falciparum M1 family aminopeptidase (Poreba et al. , 2012 ) . These results demonstrate that LAP, like many other M17 family members, has a broad substrate range, and show that Leu is not the primary substrate of LAP. This conclusion is further confirmed by the result of the Leu-AMC hydrolysis assay using bacterial lysates. Lysates from pepZ mutant bacteria demonstrated leucine aminopeptidase activity comparable with wild type lysates. Lysates from pepS mutant cells, in contrast, had significantly lower levels of activity. Together these results suggest that PepS is the primary leucine aminopeptidase of S. aureus and that LAP is active against alternative substrates, most likely alanine and arginine.
An examination of the unnatural amino acid substrates that are hydrolyzed by LAP reveals some interesting information regarding substrate preference. As expected for an aminopeptidase, substrates lacking an α -amine group were not hydrolyzed. In addition, the substrates most preferred by LAP, in general, contain large hydrophobic side chains (hPhe, hArg, Phg, hCha and Nle). This finding is similar to results found with human aminopeptidases and suggests that the substrate binding pocket is relatively large and can accommodate bulky side chains (Kasperkiewicz et al. , 2012 ) .
Bovine lens LAP (blLAP) is one of the best-studied LAP family members. It has been shown to contain two Zn 2 + ions in the active site of the enzyme, which are fundamental for activity (Kim and Lipscomb , 1993 . Previously it has been shown that the introduction of Mn 2 + into site 1 alters the activity of blLAP, making it active against the dipeptide cysteineglycine (Cappiello et al. , 2004 (Cappiello et al. , , 2006 . M17 family members from prokaryotes have also been shown to demonstrate cysteinylglycinase activity, and in some cases cysteinylglycinase activity is greater than leucine aminopeptidase activity (Suzuki et al. , 2001 ; Chu et al. , 2008 ) .
We investigated the cysteinylglycinase activity of S. aureus LAP using a cysteine-glycine hydrolysis assay. The results demonstrated that LAP has the ability to cleave cysteine-glycine, however only under very specific conditions, i.e., with MnCl 2 at pH 7. Cysteinylglycinase activity was not detected in the presence of metal ions other than Mn 2 + suggesting that, similarly to blLAP, occupancy of site 1 with Mn 2 + in LAP may activate the cysteinylglycinase activity of this enzyme. In contrast, the activity of LAP against Leu and other amino acids is evident under a range of different pH and metal conditions. The activity of LAP against cysteine-glycine raises interesting possibilities with regard to its role and potential targets in vivo . Cysteine-containing molecules such as glutathione ( l -γ -glutamyl-l -cysteinylglycine) are important in cellular defense against low pH, oxidative and osmotic stress; and sulfur metabolism has been shown to influence virulence (Masip et al. , 2006 , Soutourina et al. , 2009 ). In addition, certain bacterial species secrete glutathione from the cell during exponential growth and subsequently utilize it as a cysteine and glycine source during nutrient limitation (Suzuki et al. , 1993 ) . Although S. aureus does not produce glutathione, the low-molecular mass thiol bacillithiol (BSH, Cys-GlcN-mal) is thought to substitute for glutathione in this and other low-guanine-cytosine (GC) Gram-positive bacteria (Newton et al. , 2009 ) . The central role of low-molecular mass thiols in cellular physiology, and the demonstrated cysteinylglycinase activity of LAP, suggests that a role in cellular cysteine metabolism may be the mechanism by which LAP influences S. aureus virulence.
The biological significance of an aminopeptidase that can hydrolyze different substrates depending on pH and metal cofactor is intriguing and remains to be fully determined. Previously it has been reported that the intracellular pH of S. aureus cells is pH 7.4 -7.6 during growth under standard laboratory conditions (Kashket , 1981 ) . Many bacteria (including S. aureus ) can tolerate a wide range of extracellular pH conditions, but while the intracellular pH can vary it is unlikely that it undergoes such radical changes in pH (Booth , 1985 ; Cotter and Hill , 2003 ) . It is tempting to speculate that under certain conditions encountered by the bacteria during infection, the cytosolic pH could shift slightly towards either pH 7 or pH 8, and that this pH shift could influence the activity of LAP by altering its substrate preference. Likewise, the in vivo availability of transition metals, which is tightly regulated by both the host and bacteria, could result in altered enzymatic activity under certain conditions (Hood and Skaar , 2012 our knowledge of LAP and lay the foundation for further investigations to identify its cellular target and determine how it influences S. aureus pathogenesis.
Materials and methods
Strains, plasmids, primers and growth conditions
The bacterial strains, plasmids and primers used throughout this study are listed in Table 2 . Routine growth of S. aureus and E. coli was carried out as described previously in TSB and lysogeny broth (LB) respectively, at 37 ° C with shaking . Where indicated, bestatin was added to cultures at a concentration of 50 μ g ml -1
. Antibiotics were used at the following concentrations for S. aureus : chloramphenicol 5 μ g ml -1
, erythromycin 5 μ g ml -1 , and lincomycin 25 μ g ml -1
. The antibiotics used for E. coli were: ampicillin 100 μ g ml -1 , kanamycin 50 μ g ml -1 , and chloramphenicol 15 μ g ml -1
.
Leucine-AMC hydrolysis assay with bacterial lysates
Bacterial lysates were prepared as follows. Triplicate replicate cultures of each strain were synchronized and grown for 15 h. Bacterial cells were pelleted by centrifugation, resuspended in 500 μ l phosphate buffered solution, and lysed using FastPrep lysing matrix B (MP Biomedical, Santa Ana, CA, USA). Following centrifugation, cleared bacterial lysates were removed and quantifi ed using the Bradford assay ( BioRad, Hercules, CA, USA). Equal amounts of total bacterial protein were incubated with 0.2 m m Leu-AMC (Sigma, St. Louis, MO, USA) and fl uorescence measured using a BioTek Synergy (Winooski, VT, USA) 2 spectrophotometer with an excitation wavelength of 360 nm and emission wavelength of 460 nm, following 60 min ' incubation at 37 ° C.
Purification of recombinant LAP
Recombinant LAP containing a C-terminal six His tag was generated using the pET24d plasmid (Novagen, Billerica, MA, USA) as follows. The pepZ gene was amplifi ed by polymerase chain reaction using primers OL558 and OL559, which contained restriction enzyme sites for NcoI and XhoI, respectively. The resulting fragment was cloned into pET24d to create plasmid pRKC1281, which contains the pepZ gene followed by six His codons and a stop codon. Plasmid pRKC1281 was transformed into BL21 (DE3) pLysS and the expression of LAPHis was induced with 1 m m IPTG for 3 h. Purifi cation of LAP-His was performed using Ni-nitrilotriacetic acid (NTA) agarose beads ( Qiagen, Valencia, CA, USA) according to the manufacturer ' s guidelines. Following elution, fractions containing LAP-His were pooled and dialyzed three times against phosphate buff ered solution. Glycerol was added to a fi nal concentration of 25 % and aliquots were stored at -20 ° C until needed.
Western immunoblots
Western immunoblots were performed as described previously using strains LNS1143 and LNS1207 (Table 2 ; Carroll et al. , 2012 ) . LNS1143 expresses a plasmid-encoded, His-tagged LAP, while LNS1207 contains the empty vector control. Intracellular and extracellular protein fractions from LNS1143 and LNS1207 were collected following 15 h of growth in TSB. Lysates containing intracellular protein fractions were prepared as outlined above. Extracellular protein fractions were prepared as described previously , by concentrating culture supernatants 1000-fold using Amicon (Billerica, MA, USA) centrifugal fi ltration units with a 10 KDa molecular weight cut-off .
Biofilm assay
Biofi lm assays were performed as described previously (Kolar et al. , 2011 ) .
Leucine-AMC hydrolysis assay
Hydrolysis assays were carried out in 200 μ l volumes as follows: 20 pmoles of recombinant LAP was pre-incubated in buff er containing divalent metal cations as indicated for 15 min at 37 ° C. Leu-AMC was added to a fi nal concentration of 2 m m and the reactions were incubated in a BioTek Synergy 2 spectrophotometer at 37 ° C for 60 min. At 5-min intervals, fl uorescence was measured with an excitation wavelength of 360 nm and emission wavelength of 460 nm. Data presented are the average of three replicates and the error bars represent standard deviation.
Cysteine-glycine hydrolysis assay
Cysteine-glycine hydrolysis was measured using the Gaitonde method to detect l -cysteine using the ninhydrin reagent (Gaitonde , 1967 ) . Reactions were carried out in a 200-μ l volume containing 20 pmoles of recombinant LAP, 40 m m TAPS buff er (pH as indicated), 0.2 m m divalent metal (as indicated) and 2 m m cysteine-glycine (Sigma). LAP was pre-incubated at 37 ° C for 15 min prior to the addition of the substrate. Reactions were incubated at 37 ° C for 60 min and stopped by the addition of 200 μ l acetic acid. Following this, 200 μ l of ninhydrin reagent was added (250 mg ninhydrin dissolved in 10 ml acetic acid/4 M HCl [3:2]) (Gaitonde , 1967 ) and the reactions heated to 100 ° C for 15 min. Reactions were cooled on ice and used for spectrophotometric measurements at 560 nm. Duplicate reactions containing no LAP were used to establish and subtract background values. Data presented are the average of three replicates and the error bars represent stan dard deviation.
Fluorogenic substrate fingerprint assay
The activity of LAP against a library of 60 fl uorogenic substrates was performed as previously described (Poreba et al. , 2012 ) . This library is composed of 19 proteinogenic and 41 non-proteinogenic moieties coupled to ACC, using solid-phase chemistry (Drag et al. , 2010 , Poreba et al. , 2012 . Briefl y, 40 pmoles of LAP was incubated in 40 m m TAPS buff er pH 9.0 supplemented with 0.2 m m MnCl 2 for 15 min at 37 ° C. Each substrate was added to a fi nal concentration of 0.2 m m , and the fl uorescence released was recorded using a SpectraMax (Sunnyvale, CA, USA) M5 spectrofl uorimeter plate-reader ( λ exc = 380 nm; λ em = 460 nm). The data presented are from duplicate samples with the error bars representing standard deviation.
Determination of K m and k cat
The K m and k cat values for LAP in hydrolysis reactions with Arg-ACC, Leu-ACC, hArg-ACC, Phg-ACC and cysteine-glycine were determined by performing hydrolysis assays with increasing concentrations of substrate while keeping the reaction conditions and enzyme concentration constant. Data were analyzed by generating K m and k cat values using GraphPad Prism 6 (La Jolla, CA, USA).
